ArticleJournal of inflammation research2026
Total Astragalus Saponins Modulate Ferroptosis Pathways in Cigarette Smoke and LPS-Induced Models of COPD: An in vitro and in vivo Investigation.
Article in Journal of inflammation research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition characterized by persistent airflow limitation and chronic airway inflammation. Emerging evidence indicates that ferroptosis contributes to disease pathogenesis. The current therapeutic strategies cause adverse side effects and frequent exacerbations. Methods: A COPD murine model was developed through exposure to cigarette smoke (CS) and lipopolysaccharide (LPS). We evaluated the impacts of AST on respiratory function, pulmonary index, lung pathology, and serum reactive oxygen species (ROS) and glutathione (GSH) levels in the COPD mice. Beas-2B cells were stimulated with cigarette smoke extract (CSE) to evaluate GSH, malondialdehyde (MDA), ROS, lipid peroxidation, Fe Results: In COPD mice (n=8), AST treatment significantly improved respiratory function (Penh, TV, EF50, EF75), reduced tracheal wall thickening and inflammatory cell infiltration ( Conclusion: Our findings suggest that AST exerts protective effects against CS and LPS-induced COPD in mice and CSE-induced injury in Beas-2B cells that are associated with modulation of ferroptosis-related markers. These results provide preliminary evidence supporting continued investigation of AST in preclinical COPD models and offer potential directions for future mechanistic research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.